Pediatrics, Formulation Development
A Randomized Pilot Study to Evaluate the Stability, Taste, and Palatability of a Novel Liquid Formulation of Tenapanor
2 January 2025 Read MoreDownload our articles & publications
Articles & Publications,
Pediatrics, Formulation Development
A Randomized Pilot Study to Evaluate the Stability, Taste, and Palatability of a Novel Liquid Formulation of Tenapanor
2 January 2025
Articles & Publications,
Clinical Pharmacology, Translational Pharmaceutics
Placebo-controlled First-in-Human Study of Oral TQS-168 in Healthy Volunteers
17 December 2024
Articles & Publications,
Clinical Pharmacology
In Vitro and Clinical Evaluations of UGT1A1-, P-gp-, OATP1B1-, and BCRP-Mediated Drug–Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor
17 December 2024
Articles & Publications,
First-in-Human, Clinical Pharmacology
First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367
12 March 2024
Articles & Publications,
Formulation Development
Two-Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared with Oral Tablet Reference in Healthy Male Participants
12 February 2024
Articles & Publications,
Pharmacokinetics , Pharmacodynamics
Pharmacokinetics, Pharmacodynamics and Bioavailability of ACM-001.1 (S-Pindolol Benzoate) in Healthy Volunteers
13 December 2023
Articles & Publications,
Human ADME, Clinical Pharmacology
Astrazeneca - A Phase 1 Study to Evaluate Absolute Bioavailability and Absorption, Distribution, Metabolism and Excretion of Savolitinib in Healthy Male Volunteers
6 June 2023
Articles & Publications,
Formulation Development, Human ADME, First-in-Human
Astrazeneca - Mass balance recovery and disposition of AZD4831 in humans
13 January 2023
Articles & Publications,
Pediatrics, Drug Product
Practical and operational considerations related to pediatric oral drug formulation: An industry survey
14 December 2022
Articles & Publications,
Materials Science
Controlled synthesis of SPION@SiO2 nanoparticles using design of experiments
13 December 2022
Articles & Publications,
Clinical Pharmacology
CC-99677: A Novel, Oral, Selective Covalent MK2 Inhibitor, Sustainably Reduces Pro-inflammatory Cytokine Production
23 August 2022
Articles & Publications,
Clinical Pharmacology
CC-99677, A Novel, Oral, Selective Covalent MK2 Inhibitor, Sustainably Reduces Pro-inflammatory Cytokine Production
23 August 2022
Articles & Publications,
Human ADME
ADME of opicapone in human healthy volunteers
16 June 2022
Articles & Publications,
Translational Pharmaceutics, Clinical Pharmacology, First-in-Human
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
3 May 2022
Articles & Publications,
Drug Product Optimization
A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors
15 March 2022
Articles & Publications,
Drug Product Optimization
Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14C]-Belumosudil in Healthy Men: A Phase 1, Open-Label, 2-Part Study
15 March 2022
Articles & Publications,
Drug Product Optimization
ACCP: A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors
7 March 2022
Articles & Publications,
Human ADME, Clinical Pharmacology, First-in-Human
Astrazeneca - Characterization of Clinical ADME & Pharmacokinetics of Velsecorat Using an IV Microtracer Combined with an Inhaled Dose in Healthy Subjects
2 February 2022
Articles & Publications,
Modified Release, Formulation Development
Development of a Once‑Daily Modified‑Release Formulation for the Short Half‑Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology
10 January 2022
Articles & Publications,
Clinical Pharmacology
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects
3 January 2022
Articles & Publications,
Clinical Pharmacology, First-in-Human
Dose Finding and Food Effect Studies of a Novel Abiraterone Acetate Formulation for Oral Suspension in Comparison to a Reference Formulation in Healthy Male Subjects
16 December 2021
Articles & Publications,
Human ADME, First-in-Human
Scientific Paper_Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral Administration
1 September 2021
Articles & Publications,
Bioanalysis
Scientific Paper_Inductively coupled plasma mass spectrometry method for plasma and intracellular antimony quantification applied to pharmacokinetics of meglumine antimoniate
1 May 2021
Articles & Publications,
Formulation Development, Oral Peptides
Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
1 May 2021
Articles & Publications,
Modified Release
Scientific Paper_ Development of a Prototype, Once-Daily, Modified Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772
1 February 2021
Articles & Publications,
Clinical Pharmacology
A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics
23 January 2020
Articles & Publications,
Clinical Pharmacology
2019 Jones et al - Absence of pharmacokinetic interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate ~Gen
21 January 2020
Articles & Publications,
Translational Pharmaceutics, Formulation Development, Clinical Pharmacology
Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects
23 November 2018Learn more about Quotient Sciences' services
See how we can help you with your next drug program.
